Nayanendu Saha

MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells”.

Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells

Biomedicine & Pharmacotherapy(2023)10.1016/j.biopha.2023.114494

N/A

0.483DataRank · unranked

24 citations

Du-San Baek, Rachelle Mendoza, Dorothea Robev, Yan Xu, Yehuda Goldgur +7 more

Antibodies targeting ADAM17 reverse neurite outgrowth inhibition by myelin-associated inhibitors

Life Science Alliance(2025)10.26508/lsa.202403126

N/A

0.104DataRank · unranked

1 citations

Eric Chan, Rachelle Mendoza, Yevgeniy Romin, Murray J. Tipping, Dimitar B. Nikolov +1 more

Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells

Translational Oncology(2021)10.1016/j.tranon.2021.101265

N/A

0DataRank · unranked

22 citations

Kai Xu, Zhongyu Zhu, Dorothea Robev, Teja Kalidindi, Yan Xu +6 more

Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cells

Biomedicine & Pharmacotherapy(2024)10.1016/j.biopha.2024.117605

N/A

0DataRank · unranked

4 citations

Sang Gyu Lee, Eeva‐Christine Brockmann, M. Jason de la Cruz, Yehuda Goldgur, Rachelle Mendoza +10 more